Analyze Diet

Topic:Medication

The topic of medication in horses encompasses the study and application of pharmaceutical substances used to treat, manage, or prevent diseases and conditions in equine patients. This field involves understanding the pharmacokinetics and pharmacodynamics of various drugs, including their absorption, distribution, metabolism, and excretion in horses. Medications commonly administered to horses include non-steroidal anti-inflammatory drugs (NSAIDs), antibiotics, anthelmintics, and sedatives. The appropriate use of these medications is critical for ensuring therapeutic efficacy and minimizing adverse effects. Research in this area focuses on dosage optimization, drug interactions, resistance development, and withdrawal times to ensure both the health of the horse and compliance with regulatory standards. This page aggregates peer-reviewed studies and scholarly articles that explore the pharmacological aspects, clinical applications, and regulatory considerations of equine medications.
Sustained intra-articular release of celecoxib from in situ forming gels made of acetyl-capped PCLA-PEG-PCLA triblock copolymers in horses.
Biomaterials    March 18, 2015   Volume 53 426-436 doi: 10.1016/j.biomaterials.2015.02.109
Petit A, Redout EM, van de Lest CH, de Grauw JC, Müller B, Meyboom R, van Midwoud P, Vermonden T, Hennink WE, René van Weeren P.In this study, the intra-articular tolerability and suitability for local and sustained release of an in situ forming gel composed of an acetyl-capped poly(ε-caprolactone-co-lactide)-b-poly(ethylene glycol)-b-poly(ε-caprolactone-co-lactide) (PCLA-PEG-PCLA) copolymer loaded with celecoxib was investigated in horse joints. The systems were loaded with two dosages of celecoxib, 50 mg/g ('low CLB gel') and 260 mg/g ('high CLB gel'). Subsequently, they were injected into the joints of five healthy horses. For 72 h after intra-articular injection, they induced a transient inflammatory response,...
A systematic review and meta-analysis of the efficacy of furosemide for exercise-induced pulmonary haemorrhage in Thoroughbred and Standardbred racehorses.
Equine veterinary journal    February 2, 2015   Volume 47, Issue 3 341-349 doi: 10.1111/evj.12373
Sullivan SL, Whittem T, Morley PS, Hinchcliff KW.Furosemide is the most commonly used medication for exercise-induced pulmonary haemorrhage (EIPH); however, critical evaluation of the strength of evidence for efficacy of furosemide is lacking and is warranted so that evidence-based treatment decisions can be made. Objective: To evaluate the efficacy of furosemide to reduce the severity or frequency of detection of EIPH in Thoroughbred and Standardbred racehorses. Methods: Systematic review with meta-analyses. Methods: Primary studies were identified via searches of electronic databases, relevant texts and reference lists of published article...
Nanoparticulate CpG immunotherapy in RAO-affected horses: phase I and IIa study.
Journal of veterinary internal medicine    January 27, 2015   Volume 29, Issue 1 286-293 doi: 10.1111/jvim.12524
Klier J, Lehmann B, Fuchs S, Reese S, Hirschmann A, Coester C, Winter G, Gehlen H.Recurrent airway obstruction (RAO), an asthma-like disease, is 1 of the most common allergic diseases in horses in the northern hemisphere. Hypersensitivity reactions to environmental antigens cause an allergic inflammatory response in the equine airways. Cytosine-phosphate-guanosine-oligodeoxynucleotides (CpG-ODN) are known to direct the immune system toward a Th1-pathway, and away from the pro-allergic Th2-line (Th2/Th1-shift). Gelatin nanoparticles (GNPs) are biocompatible and biodegradable immunological inert drug delivery systems that protect CpG-ODN against nuclease degeneration. Prelimi...
Opioids for field procedures in equine practice.
The Veterinary record    December 20, 2014   Volume 175, Issue 24 621-622 doi: 10.1136/vr.g7571
Schauvliege S.No abstract available
Survey of the therapeutic approach and efficacy of pentosan polysulfate for the prevention and treatment of equine osteoarthritis in veterinary practice in Australia.
Australian veterinary journal    November 27, 2014   Volume 92, Issue 12 482-487 doi: 10.1111/avj.12266
Kramer CM, Tsang AS, Koenig T, Jeffcott LB, Dart CM, Dart AJ.To survey veterinary practitioners in Australia on how they administer pentosan polysulfate (PPS) to horses and their perceptions of the efficacy of PPS for: the prevention and treatment of osteoarthritis (OA), the treatment of OA when PPS is combined with other drugs, and the efficacy of PPS compared with other disease-modifying osteoarthritic drugs. Methods: Practitioners were contacted by email, which contained a link to an online survey. Results: A total of 76 responses (34.5%) to the survey were received. Respondents most commonly used PPS as prophylactic therapy prior to competition (80....
[Feed management in horse husbandry].
Tijdschrift voor diergeneeskunde    October 3, 2014   Volume 139, Issue 9 43-45 
Errens AV.No abstract available
Pharmacokinetics of intravenous, plain oral and enteric-coated oral omeprazole in the horse.
Journal of veterinary pharmacology and therapeutics    October 1, 2014   Volume 38, Issue 2 130-136 doi: 10.1111/jvp.12169
Sykes BW, Underwood C, McGowan CM, Mills PC.The objectives were to document the pharmacokinetics of intravenous, enteric-coated oral and plain oral omeprazole in fasted horses and to investigate the impact of feeding on the bioavailability of an enteric-coated omeprazole. Twelve horses received four treatments: intravenous omeprazole (0.5 mg/kg) in the fasted state (IV-Fasted), enteric-coated omeprazole (4 mg/kg) orally in the fasted state (ECO-Fasted), enteric-coated omeprazole (4 mg/kg) orally in the fed state (ECO-Fed) and plain omeprazole (4 mg/kg) orally in the fasted state (PL-Fasted). Plasma omeprazole concentrations were det...
Re-examining EIPH in racing: stopping the Lasix?
Veterinary journal (London, England : 1997)    September 6, 2014   Volume 202, Issue 2 203 doi: 10.1016/j.tvjl.2014.09.001
Leadon DP.No abstract available
Ultrashort cationic naphthalene-derived self-assembled peptides as antimicrobial nanomaterials.
Biomacromolecules    August 7, 2014   Volume 15, Issue 9 3429-3439 doi: 10.1021/bm500981y
Laverty G, McCloskey AP, Gilmore BF, Jones DS, Zhou J, Xu B.Self-assembling dipeptides conjugated to naphthalene show considerable promise as nanomaterial structures, biomaterials, and drug delivery devices. Biomaterial infections are responsible for high rates of patient mortality and morbidity. The presence of biofilm bacteria, which thrive on implant surfaces, are a huge burden on healthcare budgets, as they are highly resistant to current therapeutic strategies. Ultrashort cationic self-assembled peptides represent a highly innovative and cost-effective strategy to form antibacterial nanomaterials. Lysine conjugated variants display the greatest po...
Comparison of the effect of two doses of omeprazole on the squamous gastric mucosa in thoroughbred racehorses.
The Veterinary record    August 5, 2014   Volume 175, Issue 10 249 doi: 10.1136/vr.102622
Sykes BW, Sykes K, Hallowell GD.No abstract available
Pharmacokinetics and pharmacodynamics of intravenous dexmedetomidine in the horse.
Journal of veterinary pharmacology and therapeutics    July 28, 2014   Volume 38, Issue 1 15-23 doi: 10.1111/jvp.12138
Rezende ML, Grimsrud KN, Stanley SD, Steffey EP, Mama KR.The aim of the study was to describe the pharmacokinetics and selected pharmacodynamics of intravenous dexmedetomidine in horses. Eight adult horses received 5 μg/kg dexmedetomidine IV. Blood samples were collected before and for 10 h after drug administration to determine dexmedetomidine plasma concentrations. Pharmacokinetic parameters were calculated using noncompartmental analysis. Data from one outlier were excluded from the statistical summary. Behavioral and physiological responses were recorded before and for 6 h after dexmedetomidine administration. Dexmedetomidine concentrations dec...
The effects of chemical and physical penetration enhancers on the percutaneous permeation of lidocaine through equine skin.
BMC veterinary research    June 20, 2014   Volume 10 138 doi: 10.1186/1746-6148-10-138
Stahl J, Kietzmann M.The effect of physical and chemical permeation enhancers on in vitro transdermal permeation of lidocaine was investigated in the horse.Therefore, the effect of six vehicles (phosphate-buffered saline (PBS), 50% ethanol, 50% propylene glycol, 50% isopropylalcohol, 50% isopropylalcohol/isopropylmyristate and 50% dimethylsulfoxide) was examined as well as the effect of microneedle pretreatment with different needle lengths on transdermal drug delivery of lidocaine.The skin was obtained from the thorax of six Warmblood horses and was stored up to two weeks at - 20°C. Franz-type diffusion cells we...
Antioxidant Potential of the Polyherbal Formulation “ImmuPlus”: A Nutritional Supplement for Horses.
Veterinary medicine international    May 4, 2014   Volume 2014 434239 doi: 10.1155/2014/434239
Cecchini S, Paciolla M, Caputo AR, Bavoso A.In order to counteract harmful effects of oxidative stress due to pathological conditions or physical exercise, horses are often administered dietary supplements having supposed high antioxidant activities. The aim of the present study was to identify the in vitro antioxidant potential of "ImmuPlus", a polyherbal formulation (Global Herbs LTD, Chichester, West Sussex, Great Britain), containing three medicinal plants (Withania somnifera, Tinospora cordifolia, and Emblica officinalis), known in Ayurveda for their use in human disease treatment. Extracts obtained by different solvents (water, me...
Effect of Postbreeding Intramuscular Administration of Deslorelin Acetate on Plasma LH and Progesterone Concentrations and Conception Rate in Mares.
Journal of equine science    April 22, 2014   Volume 25, Issue 1 23-27 doi: 10.1294/jes.25.23
Kino S, Osawa T, Mizuno S, Watanabe G, Taya K, Izaike Y.To clarify effect of postbreeding intramuscular administration of deslorelin on mares, plasma LH and progesterone concentrations and conception rate were evaluated. In Experiment 1, deslorelin, buserelin, or a placebo was administered on day 9 (day 0=day of last breeding or AI). Plasma samples were collected daily from days 6 to 15, and additional samples were taken after treatment. There was a significant increase in hormonal concentrations after deslorelin treatment. In Experiment 2, deslorelin or placebo was injected on day 9. There was no difference in conception rates at days 15 and 30 be...
Oral and injectable synthetic progestagens effectively manipulate the estrous cycle in the Przewalski’s horse (Equus ferus przewalskii).
Animal reproduction science    April 8, 2014   Volume 148, Issue 1-2 42-52 doi: 10.1016/j.anireprosci.2014.03.018
Collins CW, Monfort SL, Vick MM, Wolfe BA, Weiss RB, Keefer CL, Songsasen N.To date, there has been limited research on manipulation of the estrous cycle in endangered equids. The objectives of this study were to assess the efficacy of using combinations of: (a) oral altrenogest and PGF2α, and (b) injectable altrenogest and PGF2α for manipulation of ovarian activity in Przewalski's mares. Reproductive cycles were monitored by assessing follicular changes with rectal ultrasound and changes in urinary steroid hormones. In Study 1, five cycling mares were treated with oral altrenogest (n=11 cycles) for 14 days. In Study 2, cycling mares were treated with oral altrenoge...
Veterinary anaesthesia and analgesia: from chloroform to designer drugs.
The Veterinary record    March 29, 2014   Volume 174, Issue 13 318-321 doi: 10.1136/vr.g2249
Taylor P.No abstract available
Furosemide debate continues.
Journal of the American Veterinary Medical Association    March 15, 2014   Volume 244, Issue 4 391 
No abstract available
Efficacy of omeprazole powder paste or enteric-coated formulation in healing of gastric ulcers in horses.
Journal of veterinary internal medicine    March 14, 2014   Volume 28, Issue 3 925-933 doi: 10.1111/jvim.12341
Birkmann K, Junge HK, Maischberger E, Wehrli Eser M, Schwarzwald CC.GastroGard, an omeprazole powder paste formulation, is considered the standard treatment for gastric ulcers in horses and is highly effective. Gastrozol, an enteric-coated omeprazole formulation for horses, has recently become available, but efficacy data are controversial and sparse. Objective: To investigate the efficacy of GastroGard and Gastrozol at labeled doses (4 and 1 mg of omeprazole per kg bwt, respectively, PO q24h) in healing of gastric ulcers. Methods: 40 horses; 9.5 ± 4.6 years; 491 ± 135 kg. Methods: Prospective, randomized, blinded study. Horses with an ulcer score ≥1 (Equi...
Antimicrobial use in foals: Do we need to change how we think?
Equine veterinary journal    February 20, 2014   Volume 46, Issue 2 137-138 doi: 10.1111/evj.12178
Haggett EF.No abstract available
Controlled nail delivery of a novel lipophilic antifungal agent using various modern drug carrier systems as well as in vitro and ex vivo model systems.
Journal of controlled release : official journal of the Controlled Release Society    February 18, 2014   Volume 180 60-70 doi: 10.1016/j.jconrel.2014.02.013
Naumann S, Meyer JP, Kiesow A, Mrestani Y, Wohlrab J, Neubert RH.The penetration behavior into human nails and animal hoof membranes of a novel antifungal agent (EV-086K) for the treatment of onychomycosis was investigated in this study. The new drug provides a high lipophilicity which is adverse for penetration into nails. Therefore, four different formulations were developed, with particular focus on a colloidal carrier system (CCS) due to its penetration enhancing properties. On the one hand, ex vivo penetration experiments on human nails were performed. Afterwards the human nail plates were cut by cryomicrotome in order to quantify the drug concentratio...
Use of oral sedatives in horses.
The Veterinary record    January 7, 2014   Volume 174, Issue 1 21 doi: 10.1136/vr.f7636
Chandler K, Bowen M.No abstract available
Detection and pharmacokinetics of three formulations of firocoxib following multiple administrations to horses.
Equine veterinary journal    January 7, 2014   Volume 46, Issue 6 734-738 doi: 10.1111/evj.12211
Knych HK, Stanley SD, Arthur RM, Mitchell MM.The use of firocoxib in horses and its ability to affect performance and potential to allow a horse to compete when it otherwise should not, necessitates establishing appropriate withdrawal time guidelines prior to performance. Objective: To describe plasma concentrations and characterise the pharmacokinetics of 3 firocoxib formulations following multiple administrations of the label dose, with respect to recommended plasma thresholds for performance horses. Methods: Balanced 3-way crossover prospective study. Methods: Nine healthy mature horses were administered firocoxib injectable solution ...
The dilemmas of medicine selection for equine veterinarians.
Equine veterinary journal    December 18, 2013   Volume 46, Issue 1 15-16 doi: 10.1111/evj.12195
Chandler KJ, Sutton DG.No abstract available
Use of lomustine (CCNU) in a case of cutaneous equine lymphoma.
The Canadian veterinary journal = La revue veterinaire canadienne    December 3, 2013   Volume 54, Issue 12 1137-1141 
Doyle AJ, MacDonald VS, Bourque A.A 12-year-old gelding was diagnosed with recurrent lymphoma in multiple cutaneous sites. A highly invasive preputial mass caused urethral obstruction. The horse was treated with surgery and chemotherapy consisting of lomustine (CCNU) and prednisolone. The treatment was well-tolerated and effective. This is the first reported use of lomustine (CCNU) in a horse for the treatment of equine lymphoma. Utilisation de lomustine (CCNU) dans un cas de lymphone cutané équin. Un hongre âgé de 12 ans a été diagnostiqué avec un lymphome récurrent sur plusieurs sites cutanés. Une masse préputiale ...
Honey in wound management: myth, mystery, magic or marvel?
Veterinary journal (London, England : 1997)    October 29, 2013   Volume 199, Issue 1 5-6 doi: 10.1016/j.tvjl.2013.10.026
Knottenbelt DC.No abstract available
Control of medication in horses: detection time, withdrawal time and beyond.
Veterinary journal (London, England : 1997)    September 12, 2013   Volume 198, Issue 2 305-306 doi: 10.1016/j.tvjl.2013.08.036
Toutain PL.No abstract available
Disposition of firocoxib in equine plasma after an oral loading dose and a multiple dose regimen.
Veterinary journal (London, England : 1997)    September 4, 2013   Volume 198, Issue 2 382-385 doi: 10.1016/j.tvjl.2013.07.035
Cox S, Villarino N, Sommardahl C, Kvaternick V, Zarabadipour C, Siger L, Yarbrough J, Amicucci A, Reed K, Breeding D, Doherty T.The objective of this study was to determine if a single loading dose (LD), 3× the label dose of firocoxib oral paste, followed by nine maintenance doses at the current label dose achieves and maintains near steady state concentrations. Six healthy, adult mares were administered 0.3mg/kg of firocoxib on Day 0, and 0.1 mg/kg 24 h later on Day 1, and at 24 h intervals from Day 2 to Day 9, for a total of 10 doses. Blood samples were collected throughout the study. The mean firocoxib maximum plasma concentration and standard deviation was 199±97 ng/mL, 175±44 ng/mL and 183±50 ng/mL after the L...
Indenopyride derivative RTI-4587-073(l): a candidate for male contraception in stallions.
Theriogenology    August 30, 2013   Volume 80, Issue 9 1006-1016 doi: 10.1016/j.theriogenology.2013.07.029
Pozor MA, Macpherson ML, McDonnell SM, Nollin M, Roser JF, Love C, Runyon S, Thomas BF, Troedsson MH.The objective of this study was to determine whether an indenopyridine derivative RTI-4587-073(l) was a good candidate for male contraception in horses. We hypothesized that a single administration of RTI-4587-073(l) causes significant suppression of testicular function in stallions without affecting sexual behavior. Three Miniature horse stallions received a single dose of 12.5 mg/kg RTI-4587-073(l) orally (group "treated"), whereas three other Miniature horse stallions received placebo only (group "control"). Semen was collected and evaluated from all stallions twice a week for three baselin...
A clinician’s guide to factors affecting withdrawal times for equine therapeutic medications.
Veterinary journal (London, England : 1997)    August 6, 2013   Volume 198, Issue 2 313-321 doi: 10.1016/j.tvjl.2013.07.002
Tobin T, Dirikolu L, Brewer K, Hughes CG.Equine forensic science can now detect concentrations down to 25 femtograms/mL (parts per quadrillion, ppq) or less in blood and urine. As such, horsemen are increasingly at risk of inadvertent 'positives' due to therapeutic medication 'overages' or trace identifications of dietary or environmental substances. Reviewed here are the factors which determine detection times and 'withdrawal times' for substances administered to horses. Withdrawal times are affected by many factors, including dose, formulation, route and frequency of administration, bioavailability, plasma half-life, sensitivity of...
The pharmacokinetics of methocarbamol and guaifenesin after single intravenous and multiple-dose oral administration of methocarbamol in the horse.
Journal of veterinary pharmacology and therapeutics    July 17, 2013   Volume 37, Issue 1 25-34 doi: 10.1111/jvp.12068
Rumpler MJ, Colahan P, Sams RA.A simple LC/MSMS method has been developed and fully validated to determine concentrations and characterize the concentration vs. time course of methocarbamol (MCBL) and guaifenesin (GGE) in plasma after a single intravenous dose and multiple oral dose administrations of MCBL to conditioned Thoroughbred horses. The plasma concentration-time profiles for MCBL after a single intravenous dose of 15 mg/kg of MCBL were best described by a three-compartment model. Mean extrapolated peak (C0 ) plasma concentrations were 23.2 (± 5.93) μg/mL. Terminal half-life, volume of distribution at steady-state...
1 4 5 6 7 8 36